Frontiers in Pharmacology (Jan 2022)
Network Meta-Analysis on the Effects of SGLT2 Inhibitors Versus Finerenone on Cardiorenal Outcomes in Patients With Type 2 Diabetes and Chronic Kidney Disease
Abstract
No abstracts available.Keywords
Frontiers in Pharmacology (Jan 2022)